The objective of this study was to investigate the in vivo effect of HMA on PD-1 methylation and expression in T cells obtained from patients during 5-aza treatment, and to evaluate the rationale of combining HMA with a PD-1 pathway inhibitor in MDS. Here, PDCD1 is linked to myelodysplastic syndrome.